Antihypertensive response to combination of olmesartan and amlodipine does not depend on method and time of drug administration
- PMID: 23657962
- DOI: 10.1007/s40292-013-0013-4
Antihypertensive response to combination of olmesartan and amlodipine does not depend on method and time of drug administration
Abstract
Fixed combinations of antihypertensive drugs have the potentiality to improve blood pressure (BP) control. However, when pharmacokinetic parameters of the two drugs are different, both method and time of administration of the two drugs may modify the antihypertensive response. In an open-label, single-blind, randomized study we compared antihypertensive effect of four administration schemes of a combination therapy of olmesartan and amlodipine in the same group of hypertensive patients, using ambulatory blood pressure monitoring (ABPM). The olmesartan + amlodipine combination has demonstrated to provide a good control of BP, with systolic and diastolic BP constantly below 130 and 85 mmHg over the 24 h. The simultaneous or separate administration of the 2 drugs fully overlapped, suggesting that the fixed combination and the separate administration induce a similar and sustained BP control.
Similar articles
-
The combination of olmesartan medoxomil and amlodipine besylate in controlling high blood pressure: COACH, a randomized, double-blind, placebo-controlled, 8-week factorial efficacy and safety study.Clin Ther. 2008 Apr;30(4):587-604. doi: 10.1016/j.clinthera.2008.04.002. Clin Ther. 2008. PMID: 18498909 Clinical Trial.
-
Olmesartan medoxomil plus amlodipine increases efficacy in patients with moderate-to-severe hypertension after monotherapy: a randomized, double-blind, parallel-group, multicentre study.Clin Drug Investig. 2009;29(7):427-439. doi: 10.2165/00044011-200929070-00001. Clin Drug Investig. 2009. PMID: 19499960 Clinical Trial.
-
Pharmacokinetics of amlodipine and olmesartan after administration of amlodipine besylate and olmesartan medoxomil in separate dosage forms and as a fixed-dose combination.J Clin Pharmacol. 2008 Nov;48(11):1309-22. doi: 10.1177/0091270008322176. J Clin Pharmacol. 2008. PMID: 18974285
-
Efficacy and tolerability of olmesartan/amlodipine combination therapy in patients with mild-to-severe hypertension: focus on 24-h blood pressure control.Ther Adv Cardiovasc Dis. 2010 Oct;4(5):301-13. doi: 10.1177/1753944710380228. Ther Adv Cardiovasc Dis. 2010. PMID: 20921092 Review.
-
Fixed combinations in the management of hypertension: patient perspectives and rationale for development and utility of the olmesartan-amlodipine combination.Vasc Health Risk Manag. 2008;4(3):653-64. doi: 10.2147/vhrm.s2586. Vasc Health Risk Manag. 2008. PMID: 18827915 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical